Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T08:04:38.546Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of a Central-Line Insertion Site Assessment (CLISA) score on localized insertion site infection to prevent central-line–associated bloodstream infection (CLABSI)

Published online by Cambridge University Press:  08 November 2019

Shruti K. Gohil ,
Jennifer Yim ,
Kathleen Quan ,
Maurice Espinoza ,
Deborah J. Thompson ,
Allen P. Kong ,
Bardia Bahadori ,
Tom Tjoa ,
Chris Paiji  and
Scott Rudkin
...Show all authors
Shruti K. Gohil*
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Jennifer Yim
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California
Kathleen Quan
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California
Maurice Espinoza
Affiliation:
University of California, Irvine Health, Orange, California
Deborah J. Thompson
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California
Allen P. Kong
Affiliation:
Department of Surgery, University of California, Irvine School of Medicine, Irvine, California
Bardia Bahadori
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Tom Tjoa
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Chris Paiji
Affiliation:
Department of Medicine, University of California, Irvine School of Medicine, Irvine, California
Scott Rudkin
Affiliation:
Department of Emergency Medicine, University of California, Irvine School of Medicine, Irvine, California
Syma Rashid
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Suzie S. Hong
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Linda Dickey
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California
Mohamad N. Alsharif
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
William C. Wilson
Affiliation:
Department of Anesthesia, University of California, Irvine School of Medicine, Irvine, California University of California, Irvine Health, Orange, California
Alpesh N. Amin
Affiliation:
Department of Medicine, University of California, Irvine School of Medicine, Irvine, California University of California, Irvine Health, Orange, California
Justin Chang
Affiliation:
Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
Usme Khusbu
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California
Susan S. Huang
Affiliation:
Epidemiology & Infection Prevention Program, University of California, Irvine Health, Orange, California Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California
*
Author for correspondence: Shruti K. Gohil, Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the impact of a newly developed Central-Line Insertion Site Assessment (CLISA) score on the incidence of local inflammation or infection for CLABSI prevention.

Design:

A pre- and postintervention, quasi-experimental quality improvement study.

Setting and participants:

Adult inpatients with central venous catheters (CVCs) hospitalized in an intensive care unit or oncology ward at a large academic medical center.

Methods:

We evaluated CLISA score impact on insertion site inflammation and infection (CLISA score of 2 or 3) incidence in the baseline period (June 2014–January 2015) and the intervention period (April 2015–October 2017) using interrupted times series and generalized linear mixed-effects multivariable analyses. These were run separately for days-to-line removal from identification of a CLISA score of 2 or 3. CLISA score interrater reliability and photo quiz results were evaluated.

Results:

Among 6,957 CVCs assessed 40,846 times, percentage of lines with CLISA score of 2 or 3 in the baseline and intervention periods decreased by 78.2% (from 22.0% to 4.7%), with a significant immediate decrease in the time-series analysis (P < .001). According to the multivariable regression, the intervention was associated with lower percentage of lines with a CLISA score of 2 or 3, after adjusting for age, gender, CVC body location, and hospital unit (odds ratio, 0.15; 95% confidence interval, 0.06–0.34; P < .001). According to the multivariate regression, days to removal of lines with CLISA score of 2 or 3 was 3.19 days faster after the intervention (P < .001). Also, line dwell time decreased 37.1% from a mean of 14 days (standard deviation [SD], 10.6) to 8.8 days (SD, 9.0) (P < .001). Device utilization ratios decreased 9% from 0.64 (SD, 0.08) to 0.58 (SD, 0.06) (P = .039).

Conclusions:

The CLISA score creates a common language for assessing line infection risk and successfully promotes high compliance with best practices in timely line removal.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 1 , January 2020 , pp. 59 - 66
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: These data were presented in part at the Infectious Disease Society of America (IDSA) Annual Meeting on October 27, 2016, in San Diego, California.

References

Khong, CJ, Baggs, J, Kleinbaum, D, Cochran, R, Jernigan, JA. The likelihood of hospital readmission among patients with hospital-onset central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2015;36:886–892.CrossRefGoogle ScholarPubMed
Stevens, V, Geiger, K, Concannon, C, Nelson, RE, Brown, J, Dumyati, G. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol Infect 2014;20:O318–O324.CrossRefGoogle ScholarPubMed
Adverse events in hospitals: national incidence among medicare beneficiaries. US Department of Health and Human Services, Office of the Inspector General website. https://oig.hhs.gov/oei/reports/oei-06-09-00090.pdf. Published November 2010. Accessed March 16, 2015.Google Scholar
Dudeck, MA, Weiner, LM, Allen-Bridson, K, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module. Am J Infect Control 2013;41:1148–1166.CrossRefGoogle ScholarPubMed
Edwards, JR, Peterson, KD, Andrus, ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007;35:290–301.CrossRefGoogle ScholarPubMed
Edwards, JR, Peterson, KD, Mu, Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783–805.CrossRefGoogle ScholarPubMed
Weaver, SJ, Weeks, K, Pham, JC, Pronovost, PJ. On the CUSP: stop BSI: evaluating the relationship between central line-associated bloodstream infection rate and patient safety climate profile. Am J Infect Control 2014;42:S203–S208.CrossRefGoogle ScholarPubMed
Pronovost, PJ, Watson, SR, Goeschel, CA, Hyzy, RC, Berenholtz, SM. Sustaining reductions in central line-associated bloodstream infections in michigan intensive care units: a 10-year analysis. Am J Med Qual 2016;31:197–202.CrossRefGoogle ScholarPubMed
Preventing central line-associated bloodstream infections: a global challenge, a global perspective. The Joint Commission website. https://www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf. Published 2012. Accessed October 8, 2019.Google Scholar
O’Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162–e193.CrossRefGoogle ScholarPubMed
O’Neil, C, Ball, K, Wood, H, et al. A central-line care maintenance bundle for the prevention of central line-associated bloodstream infection in non-intensive care unit settings. Infect Control Hosp Epidemiol 2016;37:692–698.CrossRefGoogle ScholarPubMed
O’Grady, NP, Alexander, M, Burns, LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:1087–1099.CrossRefGoogle ScholarPubMed
Mermel, LA. What is the predominant source of intravascular catheter infections? Clin Infect Dis 2011;52:211–212.CrossRefGoogle ScholarPubMed
Central-line infection. Institute for Healthcare Improvement website. http://www.ihi.org/Topics/CentralLineInfection/Pages/default.aspx. Published 2019. Accessed June 9, 2019.Google Scholar
Weeks, KR, su, YJ, Yang, T, Sawyer, M, Marsteller, JA. Influence of a multifaceted intervention on central line days in intensive care units: results of a national multisite study. Am J Infect Control 2014;42:S197–S202.CrossRefGoogle ScholarPubMed
O’Grady, NP, Alexander, M, Burns, LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:1087–1099.CrossRefGoogle ScholarPubMed
Perencevich, EN, Pittet, D. Preventing catheter-related bloodstream infections: thinking outside the checklist. JAMA 2009;301:1285–1287.CrossRefGoogle ScholarPubMed
Marschall, J, Mermel, LA, Classen, D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29 suppl 1:S22–S30.CrossRefGoogle Scholar
Crnich, CJ, Maki, DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002;34:1362–1368.CrossRefGoogle ScholarPubMed
Zack, J. Zeroing in on zero tolerance for central line-associated bacteremia. Am J Infect Control 2008;36:S176, e1–e2.CrossRefGoogle ScholarPubMed
Munoz-Price, LS, Dezfulian, C, Wyckoff, M, et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med 2012;40:1464–1469.CrossRefGoogle ScholarPubMed
Braden, BJ, Bergstrom, N. Clinical utility of the Braden scale for predicting pressure sore risk. Decubitus 1989;2:44–51.Google ScholarPubMed
Comfort, EH. Reducing pressure ulcer incidence through Braden scale risk assessment and support surface use. Adv Skin Wound Care 2008;21:330–334.CrossRefGoogle ScholarPubMed
Gohil, S, Yim, J, Espinoza, M, Bhatia, S, Paiji, C, Huang, SS. Introducing a central line insertion site assessment (CLISA) staging tool to standardize appraisal of high-risk insertion sites. Presented at the Society for Healthcare Epidemiology of America Conference, October 7–11, 2015, Orlando, FL.Google Scholar
Quan, KA, Cousins, SM, Porter, DD, et al. Electronic health record solutions to reduce central line-associated bloodstream infections by enhancing documentation of central line insertion practices, line days, and daily line necessity. Am J Infect Control 2016;44:438–443.CrossRefGoogle ScholarPubMed
Valsamis, EM, Ricketts, D, Husband, H, Rogers, BA. Segmented linear regression models for assessing change in retrospective studies in healthcare. Comput Math Methods Med 2019;2019:9810675.CrossRefGoogle Scholar
Bayer, AS. Endocarditis and intravascular infections. In: Mandell, GL, Bennett, JE, Dolin, R, Principles and Practice of Infectious Diseases. 5th ed. Oxford, UK: Elsevier; 2000.Google Scholar
Andes, DR, Urban, AW, Acher, CW, Maki, DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med 1998;105:446–450.CrossRefGoogle ScholarPubMed
Raad, II, Hohn, DC, Gilbreath, BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.CrossRefGoogle ScholarPubMed
O’Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39:S1–S34.CrossRefGoogle ScholarPubMed
Safdar, N, Maki, DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002;30:2632–1635.CrossRefGoogle Scholar